IAM's Role in the Pharmaceutical SectorSandy Dalal of Allergan on Achieving Security Stability
Mergers and acquisitions, along with cloud adoption, are rapidly changing the pharmaceutical industry. Sandy Dalal of Allergan talks about how Okta identity and access management brings security stability and supports a zero trust framework.
See Also: The Global State of Online Digital Trust
In an interview at Information Security Media Group's recent Healthcare Security Summit in New York, Dalal discusses:
- How the cloud is changing the pharmaceutical market;
- Why zero trust is essential in an era of mergers and acquisitions;
- How identity and access management can make the onboarding process more efficient and secure.
Dalal is director of identity and access management services at the pharmaceutical company Allergan. He is accountable for global service delivery and lifecycle management of identity, account management and end-user access management processes. Prior to joining Allergan, Dalal was a senior manager in PwC's advisory cybersecurity and privacy practice.